Minovia Therapeutics is a clinical-stage international biotechnology company, established in hopes to bring life changing therapies to patients with Mitochondrial diseases, as fast as responsible. 
Following compassionate use cases performed in Sheba Medical hospital in Israel, using our proprietary Mitochondrial Augmentation Therapy, Minovia is now conducting the first of its kind clinical trial for Pearson syndrome, an ultra-rare pediatric disease. 

Biotechnology

Life Sciences

Therapeutics

Minovia Therapeutics

Natalie Yivgi-Ohana

Shmulik Polak

Nadav Eshkol

Limor Lior

Noa Sher

The Leadership Team at Minovia Therapeutics drives the strategic vision and operational execution of the company. This includes overseeing clinical trials for mitochondrial diseases, fostering a culture of innovation and collaboration, and ensuring that all departments align with the goal of delivering life-changing therapies to patients swiftly and responsibly.

Leadership Team

Clinical and Research Team

Leadership Team

About

Team members

Other teams at Minovia Therapeutics

Clinical and Research Team